当前位置: X-MOL 学术medRxiv. Endocrinol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Prevalence of Macroprolactin in Hyperprolactinemic patients receiving Anti-psychotics
medRxiv - Endocrinology Pub Date : 2021-05-11 , DOI: 10.1101/2021.05.11.21256928
Loai Ali Al Mortada Al Wasify , Shaikha Said Al Maamary , Mohammed Nasser Rashid Al Tobi

Background: Prolactin (PRL) hormone circulates in the blood in three forms, mono-prolactin which constitutes 85 % of prolactin in healthy and hyperprolactinemia conditions, a dimeric prolactin (big PRL) and polymeric PRL (big-big prolactin or Macroprolactin). Macroprolactin in normal conditions is not exceeding 2% of the total serum prolactin and had no biological activity. In some cases, of hyperprolactinemia the dominant form becomes MaPRL and exceeding the 2% percentage of total leading to misdiagnosis of hyperprolactinemia and un-necessary radiological investigations. The aim of this study is to detect the prevalence of MaPRL in Psychiatric patients with hyperprolactinemia due to anti-psychotic medications at Al Masarra hospital. Material and methods: The study was conducted on 190 samples from patients with high prolactin in Al Masarra Hospital either inpatients or out-patient clinics either male or non-lactating not pregnant female. The measurement of Prolactin level was measured by the automated analyser COBAS e411, Roche Diagnostic. Macroprolactin was precipitated by using Polyethylene glycol (PEG). Results: Prevalence of Macroprolactin was 10.5 % of hyperprolactinemic patients receiving antipsychotics. There was a statistically significant difference in gender between the symptomatic and asymptomatic group. There was no significant difference in medications used between the symptomatic and asymptomatic group and there was a statistically significant difference in total Prolactin & Macroprolactin between males and females. Conclusions: Investigation for Macroprolactin should be done in every hyperprolactinemia patient who is receiving antipsychotics more especially the asymptomatic cases to avoid unnecessary radiological imaging and treatment.

中文翻译:

大催乳素在接受抗精神病药治疗的高泌乳素血症患者中的患病率

背景:催乳素(PRL)激素以三种形式在血液中循环,在健康和高泌乳素血症的情况下,单催乳素占催乳素的85%,二聚催乳素(大PRL)和聚合PRL(大催乳素或大催乳素)。在正常情况下,大泌乳素不超过总血清泌乳素的2%,并且没有生物学活性。在某些情况下,高催乳素血症的显性形式为MaPRL,超过总比例的2%,会导致高催乳素血症的误诊和不必要的放射学检查。这项研究的目的是检测在Al Masarra医院使用抗精神病药物治疗的高催乳素血症精神病患者中MaPRL的患病率。材料与方法:该研究是在Al Masarra医院住院或门诊的男性或非哺乳期未怀孕女性的190位高催乳素样本中进行的。催乳素水平的测量是通过自动分析仪COBAS e411(罗氏诊断公司(Roche Diagnostic))进行的。通过使用聚乙二醇(PEG)沉淀大催乳素。结果:接受抗精神病药治疗的高泌乳素血症患者中大泌乳素的患病率为10.5%。有症状组和无症状组之间的性别差异有统计学意义。有症状组和无症状组之间使用的药物没有显着差异,男性和女性之间总催乳素和大泌乳素的统计学差异也有统计学意义。结论:
更新日期:2021-05-12
down
wechat
bug